Zdrowie i gospodarka · 01/06/2020
FDA Establishes Docket for Rare Disease Clinical Trials Network
The FDA is seeking input from patients, healthcare professionals, and industry experts on establishing a network of clinical trials for rare diseases, with the goal of improving treatment options and patient outcomes.
Source: Federal Register — Food and Drug AdministrationOpen original release →